Vitamin D dose response is underestimated by Endocrine Society's Clinical Practice Guideline
Open Access
- 1 June 2013
- journal article
- Published by Bioscientifica in Endocrine Connections
- Vol. 2 (2), 87-95
- https://doi.org/10.1530/ec-13-0008
Abstract
The recommended daily intakes of vitamin D according to the recent Clinical Practice Guideline (CPG) of the Endocrine Society are three- to fivefold higher than the Institute of Medicine (IOM) report. We speculated that these differences could be explained by different mathematical approaches to the vitamin D dose response. Studies were selected if the daily dose was ≤2000 IU/day, the duration exceeded 3 months, and 25-hydroxyvitamin D (25OHD) concentrations were measured at baseline and post-therapy. The rate constant was estimated according to the CPG approach. The achieved 25OHD result was estimated according to the following: i) the regression equation approach of the IOM; ii) the regression approach of the Vitamin D Supplementation in Older Subjects (ViDOS) study; and iii) the CPG approach using a rate constant of 2.5 (CPG2.5) and a rate constant of 5.0 (CPG5.0). The difference between the expected and the observed 25OHD result was expressed as a percentage of observed and analyzed for significance against a value of 0% for the four groups. Forty-one studies were analyzed. The mean (95% CI) rate constant was 5.3 (4.4–6.2) nmol/l per 100 IU per day, on average twofold higher than the CPG rate constant. The mean (95% CI) for the difference between the expected and observed expressed as a percentage of observed was as follows: i) IOM, −7 (−16,+2)% (t=1.64, P=0.110); ii) ViDOS, +2 (−8,+12)% (t=0.40, P=0.69); iii) CPG2.5, −21 (−27,−15)% (t=7.2, Pt=0.91, P=0.366). The CPG ‘rule of thumb’ should be doubled to 5.0 nmol/l (2.0 ng/ml) per 100 IU per day, adopting a more risk-averse position.Keywords
This publication has 54 references indexed in Scilit:
- A Systematic Review: Influence of Vitamin D Supplementation on Serum 25-Hydroxyvitamin D ConcentrationJournal of Clinical Endocrinology & Metabolism, 2012
- Guidelines for Preventing and Treating Vitamin D Deficiency and Insufficiency RevisitedJournal of Clinical Endocrinology & Metabolism, 2012
- Clinical and laboratory safety of one year's use of acombination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: Results of a mlticenter, rndomized, double-blind, placebo-controlled studyClinical Therapeutics, 2005
- Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trialThe Lancet, 2005
- Comparison of the effects of calcium loading with calcium citrate or calcium carbonate on bone turnover in postmenopausal womenOsteoporosis International, 2004
- A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) StudyAge and Ageing, 2003
- Effects on bone mineral density of calcium and vitamin D supplementation in elderly women with vitamin D deficiencyJoint Bone Spine, 2003
- Long-term effects of nutrient intervention on markers of bone remodeling and calciotropic hormones in late-postmenopausal womenThe American Journal of Clinical Nutrition, 2002
- Combined Calcium and Vitamin D3 Supplementation in Elderly Women: Confirmation of Reversal of Secondary Hyperparathyroidism and Hip Fracture Risk: The Decalyos II StudyOsteoporosis International, 2002
- Ultraviolet Irradiation Corrects Vitamin D Deficiency and Suppresses Secondary Hyperparathyroidism in the ElderlyJournal of Bone and Mineral Research, 1998